Segmed

Segmed is a specialized platform designed to automate the critical task of de-identifying Protected Health Information (PHI) from web-based data sources, enabling secure and compliant data sharing for research and development. Its core value proposition lies in providing a streamlined, auditable process to remove sensitive identifiers like names, dates, and medical record numbers, thereby mitigating privacy risks and helping organizations adhere to regulations such as HIPAA without manual, error-prone effort.

Key features: The platform can automatically detect and redact a wide range of PHI elements from text, including patient names, addresses, phone numbers, and specific medical codes. For example, it can process clinical notes or research datasets uploaded via a web interface, identifying and anonymizing dates of service, account numbers, and device identifiers. It provides detailed audit logs of all redactions, allowing users to verify what information was removed and ensuring the process is transparent and reproducible for compliance purposes.

What sets Segmed apart is its focus on web-accessible data and its demonstration-oriented approach, allowing users to test the de-identification process directly through its online platform without immediate commitment. While many competitors operate as enterprise backend systems, Segmed's demo platform offers immediate, hands-on validation of its capabilities. Technically, it leverages advanced natural language processing models trained specifically on medical terminology and identifier patterns to achieve high accuracy, distinguishing between clinical terms that need preservation and personal data that must be removed.

Ideal for healthcare AI researchers, clinical study coordinators, and data engineers in medical institutions who need to prepare datasets for external collaboration or public sharing. Specific use cases include anonymizing patient data from electronic health records (EHRs) before using it to train machine learning models, sanitizing case reports for academic publication, or preparing data for multi-center clinical trials where sharing identifiable information is prohibited. It is particularly valuable for startups and research teams in the digital health and medtech sectors that require a compliant, scalable method to handle sensitive data.

As a demo platform, the current offering is free to use, allowing users to explore core de-identification functionalities on sample or limited data. For full-scale, production-level data processing with higher volume limits, enterprise-grade features, and dedicated support, organizations would typically need to inquire about custom pricing plans tailored to their data throughput and compliance requirements.